| Product Information |
|
| Registration Number |
BR-1307
|
| Generic Name |
Varicella Vaccine (Live, Attenuated)
|
| Brand Name |
Varilrix
|
| Dosage Strength |
Formulation:
After reconstitution, one dose (0.5 mL) contains not less than 103.3 plaque-forming units (PFU) live attenuated varicella-zoster virus (Oka Strain).
|
| Dosage Form |
Lyophilized Powder For Injection (S.C.)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Type I colorless glass vial with bromobutyl rubber stopper and flip-off cap + 0.5 mL Type I pre-filled glass syringe (Water for Injection as diluent) with 2 separate needles (Box of 1's)
|
| Pharmacologic Category |
Vaccine
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
N/A
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
GlaxoSmithKline Philippines, Inc.
|
| Application Type |
Initial (Variation)
|
| Issuance Date |
25 July 2023
|
| Expiry Date |
25 July 2028
|